Start with a simple explanation, explore what researchers are studying, then open the science and references only when you want more detail.
Entries
44
Categories
8
Showing
44
Research Collections
Browse by research area
Compound Library
Quoted descriptions are editorial opinion wording shown for context, not Titan research findings or endorsements of efficacy, safety or medical approval. Each entry's research notes provide the qualifications.
Healing & Recovery
BPC-157
“The Repair Crew”
A 15-amino-acid healing peptide that tells your body to rebuild damaged tissue faster.
A 15-amino-acid peptide investigated predominantly in preclinical models of gastrointestinal, musculoskeletal and tissue-repair biology. Human safety and efficacy evidence is very limited. Researchers have studied tendon, ligament, muscle, bone, gastrointestinal injury and other experimental tissue-repair models. Some human research exists, but the evidence is still limited and does not establish broad effects.
Expand research notes & references
Tendon, ligament, muscle, bone, gastrointestinal injury and other experimental tissue-repair models.
A systemic healing peptide that boosts flexibility, blood flow, and whole-body recovery.
A synthetic peptide corresponding to the actin-binding 17-23 region of thymosin beta-4, investigated primarily in experimental research. Researchers have studied experimental cell migration, angiogenesis and tissue-repair biology. Studied mainly in laboratory or animal research. Human effectiveness has not been established.
Expand research notes & references
Experimental cell migration, angiogenesis and tissue-repair biology.
A copper peptide that rebuilds collagen, heals skin, and remodels aging tissue.
The copper complex of glycyl-L-histidyl-L-lysine, extensively investigated preclinically in extracellular-matrix, repair, inflammatory/redox and dermal biology. Researchers have studied matrix remodelling, epithelial and dermal repair, inflammatory/redox regulation and cosmetic skin research. Some human research exists, but the evidence is still limited and does not establish broad effects.
Expand research notes & references
Matrix remodelling, epithelial and dermal repair, inflammatory/redox regulation and cosmetic skin research.
A tiny anti-inflammatory peptide fragment loved for calming gut and skin flare-ups.
The Lys-Pro-Val tripeptide corresponding to the C-terminal region of alpha-MSH, investigated for anti-inflammatory activity in cellular and animal models. Researchers have studied intestinal epithelial/immune-cell models and mouse models of experimental colitis. Studied mainly in laboratory or animal research. Human effectiveness has not been established.
Expand research notes & references
Intestinal epithelial/immune-cell models and mouse models of experimental colitis.
A copper peptide cousin of GHK-Cu, favored for hair-follicle and skin support.
A copper-binding tripeptide complex of Ala-His-Lys investigated in experimental hair-follicle and dermal-papilla models. Researchers have studied hair-follicle elongation and dermal-papilla-cell proliferation have been investigated experimentally. Studied mainly in laboratory or animal research. Human effectiveness has not been established.
Expand research notes & references
Hair-follicle elongation and dermal-papilla-cell proliferation have been investigated experimentally.
An immune-modulating peptide that helps the body respond smarter to stress and illness.
A 28-amino-acid thymic peptide investigated as an immunomodulator across preclinical and human clinical research. Researchers have studied t-cell and broader immune regulation, infectious-disease research and adjunctive immunomodulatory applications. Studied in humans, but findings should be understood in the context of the specific studies and populations.
Expand research notes & references
T-cell and broader immune regulation, infectious-disease research and adjunctive immunomodulatory applications.
A next-gen triple-hormone agonist producing some of the biggest fat-loss numbers yet seen.
An investigational agonist of GIP, GLP-1 and glucagon receptors studied in randomized clinical trials for obesity and metabolic disease. Researchers have studied body weight, metabolic outcomes, safety and tolerability. Studied in humans, but findings should be understood in the context of the specific studies and populations.
Expand research notes & references
Body weight, metabolic outcomes, safety and tolerability.
A dual-hormone agonist that delivers strong, well-studied appetite control and fat loss.
A dual GIP- and GLP-1-receptor agonist with extensive randomized human evidence in metabolic disease and obesity. Researchers have studied glycaemic control, body weight, safety and maintenance of weight reduction. Supported by established clinical literature for specific studied or recognised contexts; this does not imply every claimed use is established.
Expand research notes & references
Glycaemic control, body weight, safety and maintenance of weight reduction.
Zepbound (tirzepatide) prescribing information - NDA 217806
A mitochondrial peptide that improves metabolic health, insulin sensitivity, and endurance.
A 16-amino-acid mitochondrial-derived peptide encoded within the mitochondrial 12S rRNA region and investigated in metabolic and ageing biology. Researchers have studied metabolic homeostasis, insulin-related biology, exercise and ageing-related metabolism. Studied mainly in laboratory or animal research. Human effectiveness has not been established.
Expand research notes & references
Metabolic homeostasis, insulin-related biology, exercise and ageing-related metabolism.
An HGH fragment engineered to burn fat without touching blood sugar or overall growth.
A synthetic analogue derived from the C-terminal 176-191 region of human growth hormone, investigated for metabolic and lipolytic effects. Researchers have studied lipolytic activity in obese-animal models. Some human research exists, but the evidence is still limited and does not establish broad effects.
Expand research notes & references
Lipolytic activity in obese-animal models.
Investigational human development for obesity (efficacy not established).
An oral compound that blocks the NNMT enzyme your body uses to store fat.
A small-molecule inhibitor of nicotinamide N-methyltransferase investigated in cellular and mouse models of metabolic dysfunction. Researchers have studied diet-induced-obesity mouse models, adipose mass, glucose tolerance, insulin sensitivity and hepatic metabolic changes. Studied mainly in laboratory or animal research. Human effectiveness has not been established.
An early-stage compound that mimics the metabolic signals of endurance exercise.
An experimental synthetic pan-agonist of estrogen-related receptors ERRalpha, ERRbeta and ERRgamma, with greatest reported potency at ERRalpha, investigated in cells and mice. Researchers have studied err signalling, mitochondrial metabolism and exercise-like adaptations in preclinical models. Studied mainly in laboratory or animal research. Human effectiveness has not been established.
Expand research notes & references
ERR signalling, mitochondrial metabolism and exercise-like adaptations in preclinical models.
A growth-hormone-releasing peptide/secretagogue investigated in human pharmacokinetic and pharmacodynamic research. Researchers have studied human gh secretory response (pharmacokinetic/pharmacodynamic research). Studied in humans, but findings should be understood in the context of the specific studies and populations.
Expand research notes & references
Human GH secretory response (pharmacokinetic/pharmacodynamic research).
A product designation commonly used for a short-acting modified GHRH(1-29)-type peptide without the albumin-binding drug-affinity complex. Direct published human evidence specifically establishing the identity and clinical pharmacology of products labelled 'CJC-1295 without DAC' is limited. There is not enough direct evidence to establish the claimed effect or formulation.
A GH-releasing peptide clinically proven to target stubborn visceral belly fat.
A synthetic growth-hormone-releasing-factor analogue evaluated in randomized human trials for HIV-associated excess visceral abdominal fat. Researchers have studied visceral adipose tissue in hiv-associated abdominal fat accumulation. Supported by established clinical literature for specific studied or recognised contexts; this does not imply every claimed use is established.
Expand research notes & references
Visceral adipose tissue in HIV-associated abdominal fat accumulation.
A research combination of a product labelled CJC-1295 without DAC and ipamorelin. The individual components act through different GH-axis pathways, but evidence for the combination itself must not be inferred from studies of either component alone. There is not enough direct evidence to establish the claimed effect or formulation.
The biologically active 1-29 fragment of growth-hormone-releasing hormone, investigated for stimulation of pituitary GH secretion. Researchers have studied human gh secretory responses. Studied in humans, but findings should be understood in the context of the specific studies and populations.
The real, full-length growth hormone — the most powerful (and most serious) tool for growth, recovery, and repair.
Human growth hormone is a 191-amino-acid pituitary protein. Recombinant human growth hormone is known as somatropin. Researchers have studied growth-hormone receptor signalling and downstream igf-1 signalling. Supported by established clinical literature for specific studied or recognised contexts; this does not imply every claimed use is established.
Expand research notes & references
Growth-hormone receptor signalling and downstream IGF-1 signalling.
Pharmaceutical-grade synthetic HGH — identical to your body's own growth hormone.
Recombinant human growth hormone corresponding to the 191-amino-acid sequence of pituitary human growth hormone. Researchers have studied growth-hormone receptor signalling. Supported by established clinical literature for specific studied or recognised contexts; this does not imply every claimed use is established.
A gonadotropin preparation providing FSH and LH biological activity, extensively studied in reproductive endocrinology. Researchers have studied follicular development and gonadotropin-dependent reproductive function. Supported by established clinical literature for specific studied or recognised contexts; this does not imply every claimed use is established.
Expand research notes & references
Follicular development and gonadotropin-dependent reproductive function.
A synthetic tetrapeptide Ala-Glu-Asp-Gly investigated in cellular and preclinical ageing-related research. Researchers have studied telomerase activity and telomere biology in cell studies. Studied mainly in laboratory or animal research. Human effectiveness has not been established.
Expand research notes & references
Telomerase activity and telomere biology in cell studies.
A coenzyme central to cellular energy and DNA repair — the longevity crowd's favorite.
Nicotinamide adenine dinucleotide is an essential cellular redox coenzyme and substrate for enzymes including PARPs and sirtuins. Researchers have studied cellular redox metabolism and parp/sirtuin enzyme substrate biology. Human or other relevant findings are mixed, inconsistent or do not support a single clear conclusion.
Expand research notes & references
Cellular redox metabolism and PARP/sirtuin enzyme substrate biology.
A mitochondria-targeted peptide that protects cellular energy production and reduces oxidative stress.
A mitochondria-targeted tetrapeptide investigated in mitochondrial biology and human clinical trials. Researchers have studied primary mitochondrial myopathy and other mitochondrial/cardiovascular research settings. Human or other relevant findings are mixed, inconsistent or do not support a single clear conclusion.
Expand research notes & references
Primary mitochondrial myopathy and other mitochondrial/cardiovascular research settings.
An experimental senolytic peptide designed to clear aged, dysfunctional 'zombie' cells.
An experimental D-retro-inverso peptide designed to interfere with FOXO4-p53 interaction and investigated as a senolytic strategy in cellular and animal models. Researchers have studied senescent-cell survival/apoptosis and age-associated tissue phenotypes in preclinical models. Studied mainly in laboratory or animal research. Human effectiveness has not been established.
Expand research notes & references
Senescent-cell survival/apoptosis and age-associated tissue phenotypes in preclinical models.
The body's master antioxidant — central to detox, immune function, and glowing skin.
An endogenous tripeptide, glutamyl-cysteinyl-glycine, central to intracellular redox biology and glutathione-dependent detoxification pathways. Researchers have studied intracellular redox biology and glutathione-dependent detoxification. Studied in humans, but findings should be understood in the context of the specific studies and populations.
Expand research notes & references
Intracellular redox biology and glutathione-dependent detoxification.
Skin pigmentation (oral/topical human studies of heterogeneous quality).
A nootropic peptide for sharp focus, memory, and a resilient, motivated mood.
A synthetic ACTH(4-10)-related heptapeptide, Met-Glu-His-Phe-Pro-Gly-Pro, investigated in neurobiological and clinical research. Researchers have studied bdnf/trkb and neurotransmitter signalling in animal/cellular models. Some human research exists, but the evidence is still limited and does not establish broad effects.
Expand research notes & references
BDNF/TrkB and neurotransmitter signalling in animal/cellular models.
Human clinical research including ischemic stroke (limited).
An anti-anxiety nootropic that brings calm focus without sedation or dependency.
A synthetic tuftsin-related peptide investigated in preclinical and relatively small human studies of anxiety-related outcomes. Researchers have studied anxiety-related outcomes in small human comparative studies. Some human research exists, but the evidence is still limited and does not establish broad effects.
Expand research notes & references
Anxiety-related outcomes in small human comparative studies.
A sleep-focused peptide that helps you fall into deeper, more restorative delta-wave sleep.
A peptide historically investigated in relation to sleep and neuroendocrine physiology, with inconsistent human sleep findings. Researchers have studied a small double-blind study in chronic insomnia reported weak objective changes but concluded short-term dsip treatment was unlikely to provide major therapeutic benefit. Some human research exists, but the evidence is still limited and does not establish broad effects.
Expand research notes & references
A small double-blind study in chronic insomnia reported weak objective changes but concluded short-term DSIP treatment was unlikely to provide major therapeutic benefit.
A libido-boosting peptide that works through the brain, not the bloodstream — for men and women.
A melanocortin receptor agonist with randomized human clinical evidence relating to sexual desire. Researchers have studied two phase iii randomized placebo-controlled trials evaluated bremelanotide in premenopausal women with hypoactive sexual desire disorder. Studied in humans, but findings should be understood in the context of the specific studies and populations.
Expand research notes & references
Two Phase III randomized placebo-controlled trials evaluated bremelanotide in premenopausal women with hypoactive sexual desire disorder.
The upstream signal that kickstarts your body's entire natural sex-hormone cascade.
Kisspeptins are KISS1-derived neuropeptides that activate KISS1R and regulate hypothalamic GnRH signalling. Researchers have studied reproductive-axis stimulation (kisspeptin-54 human study). Studied in humans, but findings should be understood in the context of the specific studies and populations.
Expand research notes & references
Reproductive-axis stimulation (kisspeptin-54 human study).
Synthetic gonadotropin-releasing hormone corresponding to endogenous GnRH, acting at the pituitary to regulate LH and FSH secretion. Researchers have studied hypothalamic-pituitary-gonadal signalling and reproductive endocrinology. Supported by established clinical literature for specific studied or recognised contexts; this does not imply every claimed use is established.
Expand research notes & references
Hypothalamic-pituitary-gonadal signalling and reproductive endocrinology.
Gonadorelin acetate (Lutrepulse) regulatory record
A glycoprotein reproductive hormone that signals through the luteinising-hormone/chorionic-gonadotropin receptor. Researchers have studied lhcgr signalling in reproductive endocrinology. Supported by established clinical literature for specific studied or recognised contexts; this does not imply every claimed use is established.
Afamelanotide is a synthetic alpha-MSH analogue and MC1R agonist with human clinical evidence in erythropoietic protoporphyria. Researchers have studied erythropoietic protoporphyria (afamelanotide clinical trials). Supported by established clinical literature for specific studied or recognised contexts; this does not imply every claimed use is established.
A tanning peptide that also boosts libido — the original, less selective Melanotan.
A synthetic cyclic melanocortin agonist investigated experimentally in humans for pigmentation and sexual effects. Researchers have studied pigmentation and sexual-response physiology. Studied in humans, but findings should be understood in the context of the specific studies and populations.
A topical 'Botox-like' peptide that relaxes facial muscles to soften expression lines.
A synthetic cosmetic peptide investigated as an ingredient in topical/microneedle formulations intended to affect the appearance of wrinkles. Researchers have studied appearance of wrinkles in multi-ingredient cosmetic formulations. Some human research exists, but the evidence is still limited and does not establish broad effects.
Expand research notes & references
Appearance of wrinkles in multi-ingredient cosmetic formulations.
The foundational anabolic hormone underneath every serious mass, strength, and vitality protocol.
The principal endogenous androgen, acting through the androgen receptor and extensively studied in human physiology and clinical research. Researchers have studied controlled human dose-response studies demonstrate concentration-dependent changes in fat-free mass, muscle size, strength and power. Supported by established clinical literature for specific studied or recognised contexts; this does not imply every claimed use is established.
Expand research notes & references
Controlled human dose-response studies demonstrate concentration-dependent changes in fat-free mass, muscle size, strength and power.
A long-acting mass builder famous for being unusually kind to joints under heavy loads.
A long-acting ester of the anabolic-androgenic steroid nandrolone with published human clinical research. Researchers have studied randomized human studies have demonstrated increases in lean mass in particular populations. Studied in humans, but findings should be understood in the context of the specific studies and populations.
Expand research notes & references
Randomized human studies have demonstrated increases in lean mass in particular populations.
Methenolone is an anabolic-androgenic steroid that has existed in acetate and enanthate ester forms. Researchers have studied early experimental pharmacology / animal research. Some human research exists, but the evidence is still limited and does not establish broad effects.
Expand research notes & references
Early experimental pharmacology / animal research.
An extremely powerful anabolic for advanced users only — big results, but a harsh side-effect profile.
A potent synthetic anabolic-androgenic steroid whose experimental anabolic literature is substantially based on animal and veterinary research. Researchers have studied androgen-sensitive effects on muscle, bone and adiposity in animal (preclinical) models. Studied mainly in laboratory or animal research. Human effectiveness has not been established.
Expand research notes & references
Androgen-sensitive effects on muscle, bone and adiposity in animal (preclinical) models.
An erythropoietin-derived peptide studied for nerve repair and inflammation, without EPO's blood-thickening effects.
An 11-amino-acid non-haematopoietic peptide derived from erythropoietin structure and investigated for tissue-protective and anti-inflammatory signalling. Researchers have studied neuropathic symptoms, corneal small-nerve-fibre density and other small-fibre-neuropathy measures in small controlled studies. these findings are not generalised to treatment of neuropathy generally. Studied in humans, but findings should be understood in the context of the specific studies and populations.
Expand research notes & references
Neuropathic symptoms, corneal small-nerve-fibre density and other small-fibre-neuropathy measures in small controlled studies. These findings are not generalised to treatment of neuropathy generally.
A designer nootropic peptide built by adding an adamantane group to Semax for claimed extra stability and potency.
A research compound marketed as an adamantane-modified Semax-related peptide. A sufficiently reliable primary published evidence base establishing its identity, pharmacology and human effects was not identified for verification. There is not enough direct evidence to establish the claimed effect or formulation.
An all-in-one repair blend combining local healing, systemic recovery, and tissue remodeling.
A Titan research blend containing BPC-157, TB-500 and GHK-Cu. The individual components have separate research literatures, but this combination itself has not been established by published combination trials identified in this verification. There is not enough direct evidence to establish the claimed effect or formulation.
The GLOW blend plus KPV, adding extra anti-inflammatory power for gut and skin issues.
A Titan research blend containing BPC-157, TB-500, GHK-Cu and KPV. Each component has a separate evidence base; direct published evidence for the combined formulation was not established in this verification. There is not enough direct evidence to establish the claimed effect or formulation.
The legendary injury-recovery duo — local repair plus systemic healing for a comeback worthy of the name.
A Titan research blend containing BPC-157 and TB-500. The components have separate predominantly preclinical research literatures; direct published evidence for this combination was not established in this verification. There is not enough direct evidence to establish the claimed effect or formulation.
Research level tells you what kind of evidence is cited for an entry. It is not a score for effectiveness, safety or suitability.
Established clinical literature
A substantial clinical literature exists for specific studied or recognised contexts.
Human clinical evidence
The compound has been studied in humans, but conclusions remain specific to those studies and populations.
Limited human evidence
Some human research exists, but it is too limited to support broad conclusions.
Preclinical evidence
Evidence is mainly from laboratory or animal research. Human effectiveness has not been established.
Mixed / conflicting
Relevant findings are inconsistent or do not support one clear conclusion.
Insufficient evidence
There is not enough direct evidence to establish the claimed effect or formulation.
Titan Research Lab
Titan Blends
Explore the individual research ingredients found in Titan blend formulations. Ingredient research does not establish the effects of a combined formulation.
Combined formulation evidence: Evidence relating to individual ingredients does not establish the effects, safety or efficacy of the combined formulation. No direct published research on this specific combination is referenced here unless listed below.